Annovis Historical Valuation

ANVS
 Stock
  

USD 11.48  0.77  6.29%   

Some fundamental drivers such as market cap or Annovis Bio enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Annovis Bio valuation indicators such as Average Equity of 38.8 M or Enterprise Value of 89.9 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Annovis Bio's future value. Financial Statement Analysis is much more than just reviewing and breaking down Annovis Bio prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Annovis Bio is a good buy for the upcoming year.
Please continue to Trending Equities.
  
Refresh
Share

About Annovis Valuation Data Analysis

Valuation is the financial process of determining what Annovis Bio is worth. Annovis Bio valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Annovis Bio valuation ratios help investors to determine whether Annovis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Annovis with respect to the benefits of owning Annovis Bio security.

Annovis Bio Valuation Data Chart

Annovis valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of Annovis equity instrument and the benefits of owning shares of Annovis Bio.
Annovis Bio Tangible Asset Value is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Tangible Asset Value of 46 Million. As of 06/29/2022, Working Capital is likely to grow to about 48 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (14.9 M).

Average Assets

Average asset value for the period used in calculation of Return on Average Equity and Return on Average Assets; derived from Total Assets.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Annovis Bio theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Annovis Bio debt, but would also pocket its cash. Enterprise Value is more accurate representation of Annovis Bio value than its market capitalization because it takes into account all of Annovis Bio existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Annovis Bio. There are two different methods for calculating Annovis Bio invested capital: operating approach and financing approach. Understanding Annovis Bio invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed. Invested capital is an input into the calculation of [ROIC]; and is calculated as: Total Debt plus Total Assets minus [Intangibles] minus Cash and Equivalents minus Current Liabilities. Please note this calculation method is subject to change.

Market Capitalization

Market capitalization (or market cap) is the total value of the shares outstanding of Annovis Bio. It is equal to Annovis Bio current share price times the number of Annovis Bio outstanding shares. Represents the product of [SharesBas]; [Price] and [ShareFactor].
Most indicators from Annovis Bio valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into Annovis Bio current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please continue to Trending Equities.Annovis Bio Tangible Asset Value is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Tangible Asset Value of 46 Million. As of 06/29/2022, Working Capital is likely to grow to about 48 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (14.9 M).
 2021 2022 (projected)
Tangible Asset Value46 M49.63 M
Market Capitalization142.41 M131.22 M

Annovis Bio valuation accounts Correlations

Annovis Bio Account Relationship Matchups

Annovis Bio Investors Sentiment

The influence of Annovis Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Annovis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Annovis Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Annovis Bio's short interest history, or implied volatility extrapolated from Annovis Bio options trading.

Current Sentiment - ANVS

Annovis Bio Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in Annovis Bio. What is your sentiment towards investing in Annovis Bio? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish

Pair Trading with Annovis Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will appreciate offsetting losses from the drop in the long position's value.

Annovis Bio Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Annovis Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis Bio to buy it.
The correlation of Annovis Bio is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
100 M
Return On Assets
-0.44
Return On Equity
-0.74
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.